Navigation Links
Gene May Boost Death Risk From Most Common Thyroid Cancer
Date:4/12/2013

FRIDAY, April 12 (HealthDay News) -- Researchers have pinpointed a genetic mutation that is strongly associated with an increased risk of death in people with thyroid cancer.

The investigators followed more than 1,800 patients after their initial treatment for papillary thyroid cancer, which accounts for 85 percent to 90 percent of all thyroid cancers.

After an average follow-up period of 33 months, 5 percent of those with the BRAF V600E mutation had died, compared with 1 percent of those without the mutation, according to the study in the April 10 issue of the Journal of the American Medical Association.

However, the link between this mutation and increased risk of death was not independent of tumor characteristics, the study authors noted in a journal news release.

This, and the fact that the overall death rate from papillary thyroid cancer is low, means that it is unclear how to use these findings to reduce death risk in patients with this type of cancer, said Dr. Mingzhao Xing, of the Johns Hopkins University School of Medicine, and colleagues.

The overall five-year survival rate for patients with papillary thyroid cancer is 95 percent to 97 percent. It's a challenge to distinguish patients who require aggressive treatment in order to reduce their risk of death from patients who do not, the researchers explained.

Even so, the authors of an accompanying editorial pointed out that the study provided important insight.

According to the editorialists, Dr. Anne Cappola and Dr. Susan Mandel of the University of Pennsylvania, "Although these findings do not support widespread BRAF V600E testing, they do support the need for additional study of how BRAF testing can be used to improve the already excellent prognosis of patients with papillary thyroid cancer."

While the study found an association between the gene mutation and thyroid cancer survival, it did not establish a cause-and-effect relationship.

More information

The American Cancer Society has more about thyroid cancer.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, April 9, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Vitamin D proven to boost energy -- from within the cells
2. New Electronic Earplugs Protect Ears and Boost Hearing
3. R.B.I. Vision Performance Supplement Boosts Athletic Ability Naturally
4. Bigorexics Want to Boost Their Masculinity
5. Facebook a Boost for Your Self-Worth?
6. Shorter Shifts for Medical Interns May Not Boost Patient Safety
7. News Coverage of Shootings May Boost Stigma of Mental Illness
8. #1 Natural Testosterone Booster Offers No Charge International Shipping of Their Highly Popular Mens All Natural Testosterone Supplement
9. Omega XL Reports New Independent Study: Omega-3s Can Boost Children’s IQ
10. Scientists ID Antibody That Might Boost Cancer Therapy
11. Oxblue Construction Cameras Help Two Universities Embarked on Major Building Projects Boost Stakeholder Confidence and Improve Project Management
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene May Boost Death Risk From Most Common Thyroid Cancer
(Date:5/4/2016)... ... 2016 , ... Pharmacy Times , the leading media ... as the Pharmaceutical News Provider of the Year in the inaugural American ... and dedication of community members who strive to make the pharmaceutical purchasing industry ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco ... compact tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and NSR-9844XL . ... retail starting at $59.95) uses 2 included CR-123 batteries to produce up to ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the country's ... upcoming months, AudioEducator has lined up some informative training session for the medical ... complete compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator ...
(Date:5/4/2016)... ... May 04, 2016 , ... Warren L. Smith M.D. , ... called UTIs, have plagued people since the beginning of recorded medical history, and ... infections every year. It's not just a matter of inconvenience; bladder infections cost us ...
(Date:5/4/2016)... KS (PRWEB) , ... May 04, 2016 , ... ... Transtem™ Patient 2016, a powerful cellular therapy software application that helps blood ... treatments to patients. , Since Transtem’s initial launch, Mediware has continued to enhance ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Research and Markets has ... Keratosis Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Actinic ... Keratosis market valuations and forecast, Actinic Keratosis ...
(Date:5/3/2016)... 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen ... http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... 3, 2016   BIOTRONIK will be exhibiting ... beyond the implant at the Heart Rhythm Society,s 37 ... San Francisco . "Physicians ... quality of patient care and satisfaction possible. Part of ... and every tomorrow," said Marlou Janssen , President, ...
Breaking Medicine Technology: